Previous close | 0.5033 |
Open | 0.5300 |
Bid | 0.3780 x 200 |
Ask | 0.6156 x 200 |
Day's range | 0.4513 - 0.5351 |
52-week range | 0.4510 - 21.8000 |
Volume | |
Avg. volume | 705,340 |
Market cap | 714,691 |
Beta (5Y monthly) | 2.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | -10.4000 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
SAN FRANCISCO, May 15, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its first quarter 2024 financial results with discussion of subsequent events.
SAN FRANCISCO, May 13, 2024--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report its Q1 2024 financial results via pre-recorded conference call and webcast on Wednesday, May 15th at 1:30 PM PT / 4:30 PM ET.
SAN FRANCISCO, May 13, 2024--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the closing of its previously announced public offering of an aggregate of 4,710,000 shares of its common stock, Series A warrants to purchase up to 4,710,000 shares of common stock and Series B warrants to purchase up to 7,065,000 shares of common stock, at a combined public offering price of $0.85 per share and accompan